The prognostic impact of histological type on clinical outcomes of early-stage cervical cancer patients whom have been treated with radical surgery

J Obstet Gynaecol. 2017 Apr;37(3):347-354. doi: 10.1080/01443615.2016.1245279. Epub 2017 Jan 31.

Abstract

The aim of this study was to determine the prognostic impact of histological type among squamous cell carcinoma (SCC), adenocarcinoma (AC) and adenosquamous carcinoma (ASC) on the treatment outcome of early-stage cervical cancer patients after radical hysterectomy. The cohort comprised of 626 patients, diagnosed with stages IA2-IB1 cervical cancer between 1987 and 2013. Four hundred and one patients had SCC, 190 had AC and 35 had ASC. The 5-year disease-free survival (DFS) rates for AC, SCC and ASC were 89.3% (95%CI 83.2-93.2), 88.7% (95%CI 84.8-91.7) and 82.1% (95%CI 61.9-92.2), respectively (p = .594). In multivariate analyses, only older age and deep stromal invasion were statistically significantly associated with DFS, whereas histologic cell type was not (p = .524). Subgroup analysis showed that in the intermediate-high-risk groups, the SCC group had a significantly longer DFS, compared with the AC group or the ASC group (p = .001) while there was no DFS difference in the low-risk group. We believe that histologic cell type had no impact in low-risk early-stage cervical cancer patients. However, in the intermediate-high-risk groups, SCC is a more favourable factor for survival than AC/ASC.

Keywords: Histology; cervical cancer; prognostic; radical hysterectomy; survival.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma* / mortality
  • Adenocarcinoma* / pathology
  • Adenocarcinoma* / surgery
  • Age Factors
  • Carcinoma, Adenosquamous* / mortality
  • Carcinoma, Adenosquamous* / pathology
  • Carcinoma, Adenosquamous* / surgery
  • Chi-Square Distribution
  • Disease-Free Survival
  • Female
  • Humans
  • Hysterectomy
  • Lymph Node Excision
  • Middle Aged
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Staging
  • Neoplasms, Squamous Cell* / mortality
  • Neoplasms, Squamous Cell* / pathology
  • Neoplasms, Squamous Cell* / surgery
  • Retrospective Studies
  • Uterine Cervical Neoplasms* / mortality
  • Uterine Cervical Neoplasms* / pathology
  • Uterine Cervical Neoplasms* / surgery